UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107286-107286, Article 107286

2023

Volltextzugriff (PDF)

An unusual cause of difficult weaning in a patient with newly diagnosed small cell lung cancer

Respiratory medicine case reports, 2015-01, Vol.16 (C), p.140-142

2015

Volltextzugriff (PDF)

OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S9-S9

2024

Volltextzugriff (PDF)

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests

The European respiratory journal, 2019-04, Vol.53 (4), p.1801660

2019

Volltextzugriff (PDF)

OA05.06 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S55

2023

Volltextzugriff (PDF)

Development of a model to analyse foot biomechanics using dynamic 3D surface scanning

Computer methods in biomechanics and biomedical engineering, 2012, Vol.15 (sup1), p.85-86

2012

Volltextzugriff (PDF)

1363P Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL)

Annals of oncology, 2020-09, Vol.31, p.S871-S872

2020

Volltextzugriff (PDF)

2000P Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)

Annals of oncology, 2020-09, Vol.31, p.S1117-S1117

2020

Volltextzugriff (PDF)

1683P SARS-CoV-2 infection and lung cancer management in Europe

Annals of oncology, 2020-09, Vol.31, p.S996-S997

2020

Volltextzugriff (PDF)

1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer

Annals of oncology, 2020-09, Vol.31, p.S713-S714

2020

Volltextzugriff (PDF)

LBA37 A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)

Annals of oncology, 2022-09, Vol.33, p.S1404

2022

Volltextzugriff (PDF)

P2.04-76 Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S738-S739

2019

Volltextzugriff (PDF)

1206P UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)

Annals of oncology, 2021-09, Vol.32, p.S961-S962

2021

Volltextzugriff (PDF)

169P BEPACT lung: A prospective, multicenter, non-interventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S790-S791

2021

Volltextzugriff (PDF)

P152 Detection of nocturnal frontal lobe seizures in pediatric patients by means of accelerometers: preliminary results

European journal of paediatric neurology, 2009, Vol.13, p.S67-S67

2009

Volltextzugriff (PDF)

157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)

Immuno-oncology technology, 2023-12, Vol.20, p.100668, Article 100668

2023

Volltextzugriff (PDF)

202P The therapeutic cancer vaccine PDClung01 induces immune responses with or without anti-PD-1 treatment in patients with non-small cell lung cancer

Immuno-oncology technology, 2022-12, Vol.16, p.100313, Article 100313

2022

Volltextzugriff (PDF)

121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pembro] coformulation) with/without docetaxel in metastatic NSCLC after platinum-chemotherapy (chemo) and immunotherapy

Immuno-oncology technology, 2023-12, Vol.20, p.100593, Article 100593

2023

Volltextzugriff (PDF)

Aanpak van verworven resistentie tegen TKI's bij patiënten met een oncogeen gedreven longtumor

Tijdschrift voor geneeskunde, 2018 (21), p.1427-1434

2018

Volltextzugriff (PDF)

P32 – 1982 Clinical impact of long-term nocturnal home monitoring for detection of epileptic seizures in pediatric patients

European journal of paediatric neurology, 2013-09, Vol.17, p.S62-S63

2013

Volltextzugriff (PDF)

Rol van adjuvante therapie bij vroegtijdige stadia van niet-kleincellige longcarcinomen

Tijdschrift voor geneeskunde, 2015 (13), p.905-907

2015

Volltextzugriff (PDF)

Nieuwe behandelingsmogelijkheden voor diabetes mellitus type 2

Tijdschrift voor geneeskunde, 2008 (9), p.441-449

2008

Volltextzugriff (PDF)

Vroegtijdig longcarcinoom: optimale follow-up

Tijdschrift voor geneeskunde, 2015 (13), p.908-910

2015

Volltextzugriff (PDF)

P26.3 Accelerometers for detection of motor seizures during sleep in pediatric patients with epilepsy

European journal of paediatric neurology, 2011-05, Vol.15, p.S134-S134

2011

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Computer Science
(48)
Technology
(41)
Computer Science, Theory & Methods
(30)
Engineering
(25)
Life Sciences & Biomedicine
(25)
Humans
(23)
Engineering, Electrical & Electronic
(21)
Computer Security
(19)
Computer Science, Information Systems
(18)
Computer Networks
(16)
Security Measures
(15)
Cryptology
(14)
Computer Systems Organization And Communication Networks
(13)
Cystic Fibrosis - Genetics
(13)
Systems And Data Security
(13)
Data Protection
(12)
Male
(12)
Respiratory System
(12)
Biological And Medical Sciences
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer

An unusual cause of difficult weaning in a patient with newly diagnosed small cell lung cancer

OA01.05 Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests

OA05.06 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04

Development of a model to analyse foot biomechanics using dynamic 3D surface scanning

1363P Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL)

2000P Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)

1683P SARS-CoV-2 infection and lung cancer management in Europe

1037P Tumour mutational burden and HLA diversity by TruSight oncology 500 (TSO500) next generation sequencing panel and clinical outcome in non-small cell lung cancer

LBA37 A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)

P2.04-76 Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer

1206P UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)

1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDClung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)

169P BEPACT lung: A prospective, multicenter, non-interventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer (NSCLC)

P152 Detection of nocturnal frontal lobe seizures in pediatric patients by means of accelerometers: preliminary results

157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)

202P The therapeutic cancer vaccine PDClung01 induces immune responses with or without anti-PD-1 treatment in patients with non-small cell lung cancer

121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pembro] coformulation) with/without docetaxel in metastatic NSCLC after platinum-chemotherapy (chemo) and immunotherapy

Aanpak van verworven resistentie tegen TKI's bij patiënten met een oncogeen gedreven longtumor

P32 – 1982 Clinical impact of long-term nocturnal home monitoring for detection of epileptic seizures in pediatric patients

Rol van adjuvante therapie bij vroegtijdige stadia van niet-kleincellige longcarcinomen

Nieuwe behandelingsmogelijkheden voor diabetes mellitus type 2

Vroegtijdig longcarcinoom: optimale follow-up

P26.3 Accelerometers for detection of motor seizures during sleep in pediatric patients with epilepsy

Suchergebnisse filtern